HOLD - Entry at $146 breakout with volume and MACD confirmation, stop at $128 breakdown on volume, position sizing unchanged until confirmed.

• Q2 fundamentals (revenue +92% YoY, gross margin +1,140 bps, EBITDA positive) already in the price after V-shaped recovery from $108 to $146
• Stock at 89.7x forward earnings with 39% drawdown from 52-week high of $211
• Morgan Stanley $300 price target is 3-year story; TTM net income is negative $8.89 billion, TTM free cash flow is negative $14 billion
• Stock collapsed 48.7% from $211 to $108 in six weeks - recent volatility regime
• Technical: 50 SMA at $137.61 still below 200 SMA at $141.42 - intermediate-term downtrend not confirmed resolved
• Plan requires breakout above $146 with volume above 80 million and expanding MACD histogram - none met
• Realistic near-term risk-reward is 1.5:1 to 2:1, not 12:1 as aggressive analyst claims
• Plan's actual stop is $128, not the cited $130; Bollinger lower band at $113, 52-week low at $104.83
• CapEx moat claim flawed: $77 billion annualized CapEx vs. ~$1 operating cash flow = 8:1 capital ratio
• FCF trajectory: negative $5.4 billion in 2024, negative $14.1 billion in 2025, negative $16.8 billion in Q2 2026 alone
• Q2 raised $85.6 billion in stock - indicates capital dependence, not financial strength
• Fed sensitivity: 89% probability of zero cuts in 2026; long-duration growth asset most rate-sensitive
• ATR is 8.15; one-ATR adverse move gets to $135, two-ATR moves below stop to $127
• Conservative position: wait for confirmed breakout; adding before confirmation increases exposure to non-confirmed setup
• Conviction without confirmation is reaching for losses; plan exists to remove courage from the equation

→ vs aggressive: Q2 inflection being 'the confirmation' - actually already priced in after V-shaped recovery from $108 to $146 between late July and mid-August; circular argument conflates fundamental inflection with low-risk entry

→ vs aggressive: Morgan Stanley $300 price target treated as risk-free alpha - but Morgan Stanley doesn't underwrite downside if stock drops to $130; TTM net income negative $8.89 billion and FCF negative $14 billion are actual numbers, not aspirational ones; identity mismatch on ticker flagged in fundamental report

→ vs aggressive: Technical structure argument framing 50/200 bearish alignment as closing/bullish setup is sleight of hand - 50 SMA at $137.61 still below 200 SMA at $141.42; not confirmed until breakout above $146 with volume above 80 million and expanding MACD histogram

→ vs aggressive: Risk-reward asymmetry of 12:1 falls apart under scrutiny - cited downside to $130 (9.4%) ignores plan's actual stop at $128 and Bollinger lower band at $113; a gap to $113 means 21% actual drawdown, not 9.4%; realistic near-term risk-reward is 1.5:1 to 2:1

→ vs aggressive: CapEx moat argument mischaracterized - $77 billion annualized CapEx spending $8 for every $1 of operating cash flow is a bet, not a moat; requires continuous capital markets access, no equity disruption, no recession, Cursor remediation doesn't spiral, OpenAI doesn't deepen model-access cut

→ vs aggressive: Hawkish Fed already priced in - disagree; Polymarket pricing 89% probability of zero cuts in 2026; long-duration growth asset with 89x forward earnings and negative FCF most rate-sensitive part of universe

→ vs aggressive: 135-138 demand zone add is seductive and dangerous - adding to position when plan's invalidation level is $128 and broader structure not confirmed is increasing exposure into non-confirmed setup; ATR of 8.15 means two-ATR move from $143 gets below stop

HOLD with tightened trailing stop to 136 and defined re-engagement/exit triggers

• Q2 fundamental inflection confirmed: revenue near-doubling, 1,140 basis point gross margin expansion, EBITDA positive
• Current valuation of 89.7 times forward earnings with negative trailing free cash flow doesn't justify aggressive adding
• Existing position should be maintained (Hold) but trailing stop tightened from 128 to 136 (below 50 SMA, VWMA cluster, and 135-138 demand zone)
• Tactical add trigger: pullback to 135-138 demand zone with RSI above 50, MACD histogram not deeply negative, contracting volume - partial position at half planned increment with stop at 130
• Full re-engagement trigger: close above 146 on volume above 80 million with expanding MACD histogram
• Full exit trigger: close below 130 on volume - no questions
• Time horizon: re-evaluate if neither add nor exit triggers fire within 30 trading days
• Aggressive case R/R of 12-to-1 is overstated; realistic R/R is 1.5-to-1 to 2-to-1 when accounting for ATR, prior 48.7% drawdown, and execution risk across verticals
• CapEx moat argument challenged: 77 billion annualized CapEx versus 1 dollar operating cash flow indicates capital markets dependency, not defensibility
• Q2 equity raise of 85.6 billion signals capital access requirement rather than financial strength
• Conservative case correctly respects plan discipline but plan must adapt when fundamentals materially improve
• Macro/hawkish Fed risk already priced at 143, not at prior 211 level

→ vs aggressive: R/R math of 12-to-1 falls apart under stress; realistic R/R is 1.5-to-1 to 2-to-1 given 48.7% historical drawdown, ATR capacity, and execution risk across verticals

→ vs aggressive: 300 dollar Morgan Stanley target is 3-5 year story with embedded assumptions; treating as near-term measured move is anchoring bias

→ vs aggressive: CapEx moat argument is operationally dangerous; 8 dollars CapEx per 1 dollar operating cash flow indicates capital markets dependency, not defensibility

→ vs conservative: Plan-as-scripture approach surrenders tactical flexibility; a plan is a tool, not a religion, and underlying information has materially improved

→ vs conservative: Selective R/R math; even 1.5-to-1 R/R with high probability justifies maintaining current exposure (Hold), not just inaction

→ vs conservative: Hawkish Fed treated as one-way downside risk, but macro pressure is symmetric and already priced at 143